Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to Washington's request for confidential information.
This rejection was revealed following a official document dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
An official spokesman has since clarified that the US was seeking biological samples for scientific study and commercial gain but was unwilling to share the resulting advantages from any future medical innovations.
"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged more negotiations to secure a deal suitable to all parties so the nation's vital HIV treatment initiative can proceed.
Wider Implications
This development follows a similar case in Kenya, where a court blocked a related health funding agreement following legal challenges were filed about the safety of citizens' medical information.
After returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and accountability.
Based on statements, 16 nations in Africa have so far signed these new agreements, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, without any corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery without any certainty that the final treatments would be available to our people if a new pandemic emerge."
Sovereignty and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting systems previously set up through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential global health emergencies.
"This framework is intended to guarantee that when a nation contributes its data, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how future collaboration might be designed in a manner that honours the sovereignty and interests of both nations."
Health Experts Reaction
Medical experts said it understood the government's concerns, but suggested that negotiations should continue given that a large portion of the nation's HIV programmes depended on international support.
"In cases where specific concerns arise, including those involving data governance or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it added.
The situation emphasises the complex challenges between accepting vital international aid and safeguarding local interests in an ever more interconnected world.